We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Follow-On Biologics Approval Pathway In U.S. Not Likely Until 2007
Follow-On Biologics Approval Pathway In U.S. Not Likely Until 2007
August 24, 2005
An abbreviated approval pathway for follow-on biologics in the U.S. is not expected until at least 2007, according to experts who note the European Union (EU) could have such a framework in place by
November.